Qubiotech

Qubiotech launches a new update of Neurocloud.


The new version of the advanced medical image processing platform, Neurocloud, incorporates new functionalities to offer its users new types of studies.


Neurocloud-PET FDG:

Quantification of hypometabolism and/or hypermetabolism.

New more sensitive calculation of asymmetries between hemispheres.


Neurocloud-PET Amyloid:

Automatic MRI segmentation to calculate gray matter uptake of cortical ROIs.

Comparison of the SUVR value with validated cut-off thresholds.